Ikarovec Company

Ikarovec is a pre-clinical phase gene therapy company. Our programmes are aimed at treating common eye diseases, restoring sight and preventing blindness.

Total Funding: 3249285
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Funding Status: Seed
Employee Number: 1-10
Last Funding Type: Seed
Last Funding Date: 2020-02-05
Investors Number: 4
Founded Date: 2018-01-01
Industry: Anti-aging Therapies